Dear John,

ICYMI, Health Affairs released a Health Policy brief from Nathaniel Tran and Gilbert Gonzales exploring how public debates and enactments of both pro- and anti-LGBTQI+ policies affect LGBTQI+ populations in the places where they live, learn, work, play, and age.

This week, Robert F. Kennedy Jr's nomination as the next US health secretary advanced after a key Senate committee vote. 

If confirmed, Kennedy would be responsible for overseeing agencies that set the nation's health agenda, including the U.S. Food & Drug Administration (FDA).

For this week's Flashback Friday, let's take a look back at what Health Affairs has published on the role of FDA over the years

FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development Time

Kathleen L. Miller et al. (July 2024)

The Revolving Door In Health Care Regulation

Genevieve P. Kanter and Daniel Carpenter (September 2023)

Seven Former FDA Commissioners: The FDA Should Be An Independent Federal Agency

Robert M. Califf et al. (January 2019)

Will The New Administration’s FDA Be A Threat Or An Opportunity For The Public's Health?

Aaron S. Kesselheim and Joshua M. Sharfstein (November 2024)

An Innovation-Driven Future For The Food And Drug Administration

Brian J. Miller et al. (January 2024)

FDA Comes Under Scrutiny

Michael S. Gerber and Rob Lott (August 2023)

Published Today

The Scope of US Medical Debt w/ Kinika Young

Health Affairs' Jeff Byers welcomes Kinika Young of The Leukemia & Lymphoma Society to the program to discuss a recent final rule/advisory issued by the Consumer Financial Protection Bureau barring medical debt from US credit reports and how this rule will impact the scope of medical debt in the US today. 

Addressing The Harmfully Slow Uptake Of Race-Neutral Kidney Function Tests

Diane C. Lewis et al.